Ameriprise
RXO icon

Ameriprise’s RXO RXO Stock Holding History

Ameriprise’s Portfolio RXO Stock Details RXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.18M Sell
260,132
-10,012
-4% -$221K ﹤0.01% 2302
2026
Q1 		$3.95M Sell
270,144
-13,713
-5% -$201K ﹤0.01% 2586
2025
Q4 		$3.59M Sell
283,857
-23,969
-8% -$354K ﹤0.01% 2676
2025
Q3 		$4.73M Buy
307,826
+21,216
+7% +$342K ﹤0.01% 2492
2025
Q2 		$4.51M Sell
286,610
-36,909
-11% -$560K ﹤0.01% 2446
2025
Q1 		$6.18M Sell
323,519
-516,580
-61% -$11.3M ﹤0.01% 2145
2024
Q4 		$20M Sell
840,099
-648,829
-44% -$18.1M 0.01% 1334
2024
Q3 		$41.7M Sell
1,488,928
-20,232
-1% -$571K 0.01% 928
2024
Q2 		$39.5M Buy
1,509,160
+38,481
+3% +$800K 0.01% 921
2024
Q1 		$32.2M Sell
1,470,679
-83,113
-5% -$1.78M 0.01% 1011
2023
Q4 		$36.1M Buy
1,553,792
+660,228
+74% +$13.3M 0.01% 929
2023
Q3 		$17.6M Buy
893,564
+477,685
+115% +$9.41M 0.01% 1311
2023
Q2 		$9.43M Sell
415,879
-28,147
-6% -$567K ﹤0.01% 1824
2023
Q1 		$8.72M Buy
444,026
+280,207
+171% +$5.38M ﹤0.01% 1879
2022
Q4 		$2.82M Buy
+163,819
New +$2.91M ﹤0.01% 2648

Other funds holding RXO

OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $2.8B AUM 13.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Ameriprise's RXO Position: Q2 2026 in Review

Ameriprise reduced its RXO (RXO) stake by 3.7% in Q2 2026, selling an estimated $221K and leaving 260,132 shares worth $7.18M. The position accounts for ﹤0.01% of the portfolio, ranked #2302.

Ameriprise first reported a position in RXO in Q4 2022 and has held it in 15 quarters since. The position peaked at $41.7M in Q3 2024. 304 funds tracked by Wall St. Rank hold RXO as of Q2 2026.

  • Ameriprise held 260,132 shares of RXO worth $7.18M as of Q2 2026.
  • Ameriprise sold 10,012 RXO shares in Q2 2026, an estimated $221K.
  • RXO made up ﹤0.01% of Ameriprise's portfolio in Q2 2026, its #2302 holding.
  • Ameriprise first reported a position in RXO in Q4 2022 and has held it in 15 quarters since.
  • Ameriprise's RXO position peaked at $41.7M in Q3 2024.
  • 304 funds tracked by Wall St. Rank held RXO as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.